JUL 14, 2020 10:47 PM PDT

Antiplatelet Drug Shows Promise for Heart Attack Treatment

WRITTEN BY: Nouran Amin

A common and often dangerous side-effect of antiplatelet medications is an increase in bleeding. As such, researchers at the University of Illinois at Chicago created a therapeutic that will prevent blood clots without the chance of increased bleeding.

"Unfortunately, current antiplatelet medications prevent the blood clotting that cause heart attack and stroke but also disrupt platelets' ability to stop bleeding if a blood vessel is torn," says Xiaoping Du, a UIC professor of pharmacology and regenerative medicine at the College of Medicine who led the research. "In some cases, severe bleeding can be life-threatening. The magic of this new drug is it prevents clots but does not make people prone to bleeding, which other drugs have failed to do."

Findings were published in the journal Science Translational Medicine describes the peptide-derived nanoparticle drug called ‘M3mP6’ and can treat heart attacks in mice. The results confirm the drug's capability in reducing clotting and inflammation.

Learn more about antiplatelet medication:

Researchers were able to test the efficacy and safety of the drug in mouse models and administer the therapeutic via injection. They found that the mice had an overall improved survival as a result of improved heart function.

"It is very exciting to see such promising results in the lab and we hope to one day test this in humans," Du said.

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 06, 2020
Drug Discovery & Development
New Vaccine Shows Promise for Herpes
NOV 06, 2020
New Vaccine Shows Promise for Herpes
The World Health Organization estimates that over 500 million people have Herpes Simplex Virus Type 2 (HSV-2), a sexuall ...
NOV 08, 2020
Cell & Molecular Biology
Mouth Spray for Epidermolysis Bullosa in Development
NOV 08, 2020
Mouth Spray for Epidermolysis Bullosa in Development
Epidermolysis Bullosa (EB) is a rare genetic disorder that makes the skin incredibly fragile; it forms blisters and can ...
DEC 15, 2020
Cannabis Sciences
Could Cannabis Help in the Opioid Crisis?
DEC 15, 2020
Could Cannabis Help in the Opioid Crisis?
While cannabis is increasingly available for medicinal use, doctors largely remain unable to prescribe it to their patie ...
DEC 04, 2020
Drug Discovery & Development
OTC Drug Found Safe for Multiple Myeloma
DEC 04, 2020
OTC Drug Found Safe for Multiple Myeloma
Injecting the immune-boosting drug ‘teclistamab’ was found to be safe and effective in patients with relapse ...
DEC 09, 2020
Drug Discovery & Development
Rapid-Release Capsule for IBS
DEC 09, 2020
Rapid-Release Capsule for IBS
Researchers have developed a rapid-release capsule to treat symptoms of irritable bowel syndrome with constipation (IBS- ...
DEC 31, 2020
Immunology
Arthritis Medication Resolves Previously Untreatable Skin Condition
DEC 31, 2020
Arthritis Medication Resolves Previously Untreatable Skin Condition
Bumpy, inflamed, ring-shaped lesions on the skin—granuloma annulare (GA) is a chronic, inflammatory skin condition ...
Loading Comments...